Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Language
Publication year range
1.
Rev Bras Parasitol Vet ; 29(3): e003820, 2020.
Article in English | MEDLINE | ID: mdl-33027421

ABSTRACT

Semi-intensive equine breeding system favors gastrointestinal nematode infections. The treatment of these infections is based on the use of anthelmintics. However, the inappropriate use of these drugs has led to parasitic resistance to the available active principles. The objective of this study was to evaluate the efficacy of the main classes of antiparasitic (ATP) used in control in adult and young animals, including: benzimidazoles (fenbendazole), pyrimidines (pyrantel pamoate), macrocyclic lactones (ivermectin and moxidectin), as well as the combination of active ingredients (ivermectin + pyrantel pamoate). The study was carried out in two military establishments, located in Rio Grande do Sul (RS), from January to December, 2018. The intervals between the treatments of the animals were performed from 30 to 90 days. Coproparasitological evaluations were determined by the egg count reduction in the faeces. Cyatostomine larvae were identified in pre and post-treatment cultures. The results demonstrated the multiple parasitic resistance of cyathostomins to fenbendazole, moxidectin in young animals, and to fenbendazole, pyrantel pamoate in adult animals. Thus, it is necessary to define or diagnose parasitic resistance to assist in the creation of prophylactic parasitic control, using suppressive treatment with ATP associated with integrated alternatives. The progress of parasitic resistance can be slowed.


Subject(s)
Antinematodal Agents , Drug Resistance, Multiple , Military Personnel , Strongyle Infections, Equine , Strongylida , Animals , Antinematodal Agents/pharmacology , Antinematodal Agents/therapeutic use , Brazil , Feces/parasitology , Horses , Larva/drug effects , Parasite Egg Count/veterinary , Strongyle Infections, Equine/drug therapy , Strongyle Infections, Equine/parasitology , Strongylida/drug effects
2.
Rev. bras. parasitol. vet ; 29(3): e003820, 2020. tab
Article in English | LILACS | ID: biblio-1138095

ABSTRACT

Abstract Semi-intensive equine breeding system favors gastrointestinal nematode infections. The treatment of these infections is based on the use of anthelmintics. However, the inappropriate use of these drugs has led to parasitic resistance to the available active principles. The objective of this study was to evaluate the efficacy of the main classes of antiparasitic (ATP) used in control in adult and young animals, including: benzimidazoles (fenbendazole), pyrimidines (pyrantel pamoate), macrocyclic lactones (ivermectin and moxidectin), as well as the combination of active ingredients (ivermectin + pyrantel pamoate). The study was carried out in two military establishments, located in Rio Grande do Sul (RS), from January to December, 2018. The intervals between the treatments of the animals were performed from 30 to 90 days. Coproparasitological evaluations were determined by the egg count reduction in the faeces. Cyatostomine larvae were identified in pre and post-treatment cultures. The results demonstrated the multiple parasitic resistance of cyathostomins to fenbendazole, moxidectin in young animals, and to fenbendazole, pyrantel pamoate in adult animals. Thus, it is necessary to define or diagnose parasitic resistance to assist in the creation of prophylactic parasitic control, using suppressive treatment with ATP associated with integrated alternatives. The progress of parasitic resistance can be slowed.


Resumo O sistema semi-intensivo de criação de equinos favorece infecções por nematoides gastrointestinais. O tratamento dessas infecções é baseado no uso de anti-helmínticos. No entanto, o uso inadequado desses medicamentos levou à resistência parasitária aos princípios ativos disponíveis. O objetivo deste estudo foi avaliar a eficácia das principais classes de antiparasitários (ATP), utilizados no controle em animais adultos e jovens, incluindo: benzimidazois (fenbendazol), pirimidinas (pamoato de pirantel), lactonas macrocíclicas (ivermectina e moxidectina), bem como a combinação de ingredientes ativos (ivermectina + pamoato de pirantel). O estudo foi realizado em dois estabelecimentos militares, localizados no Rio Grande do Sul (RS), de janeiro a dezembro de 2018. Os intervalos entre os tratamentos foram realizados de 30 a 90 dias. As avaliações coproparasitológicas foram determinadas pela redução da contagem de ovos nas fezes. Foram identificadas larvas de ciatostomíneos nas coproculturas pré e pós tratamentos. Os resultados demonstraram a resistência parasitária múltipla dos ciatostomíneos ao fenbendazol, moxidectina em animais jovens, febendazole e pamoato de pirantel em animais adultos. Estabelecer o diagnóstico da resistência parasitária auxiliará na elaboração de um controle parasitário profilático, reduzindo o tratamento supressivo com ATP juntamente com alternativas de controle integrado. Dessa forma, o avanço da resistência parasitária poderá ser retardado.


Subject(s)
Animals , Strongyle Infections, Equine/parasitology , Strongyle Infections, Equine/drug therapy , Drug Resistance, Multiple , Military Personnel , Antinematodal Agents/therapeutic use , Antinematodal Agents/pharmacology , Parasite Egg Count/veterinary , Brazil , Strongylida/drug effects , Feces/parasitology , Horses , Larva/drug effects
3.
Res Vet Sci ; 115: 92-95, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28199900

ABSTRACT

Anthelmintic resistance is a serious problem for the control of equine gastrointestinal nematodes. In the present survey, 173 third stage larvae of cyathostomins were investigated from three different locations for the presence of the resistant genotype at codon 167 of the beta-tubulin gene, as this is the most prevalent mutation. The larvae from the state of Parana (n=67), Sao Paulo (n=54) and Santa Catarina (n=52), showed 61.2; 31.5 and 38.5% of the heterozygous resistant genotype - TTC/TAC, respectively. An unpublished mutation at codon 172 that results in a serine (S) to threonine (T) substitution was found in 17.9% (12/67) of samples from Parana; and 13.0% (7/54) of samples from Sao Paulo. We have compared the molecular diagnostic with the fecal egg count data (R2=-0.79) from the same farms, and consider that the use of routine molecular diagnostic in individual larva may help to determine the population genetic distribution that is associated with drug failure.


Subject(s)
Anthelmintics/pharmacology , DNA, Helminth/genetics , Drug Resistance/genetics , Strongylida/drug effects , Strongylida/genetics , Alleles , Animals , Codon , Feces/parasitology , Genotype , Horse Diseases/parasitology , Horses , Larva/drug effects , Parasite Egg Count/veterinary , Tubulin
4.
Parasitol Int ; 63(6): 835-40, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25130588

ABSTRACT

Two high doses of ivermectin (630µg/kg and 700µg/kg) that are sold commercially in Brazil were evaluated in dose-and-slaughter trials with 144 naturally nematode-infected cattle from eight regions within the states of Minas Gerias, São Paulo and Rio Grande do Sul in Brazil. Treatment groups were based on fecal egg counts 1, 2, and 3days before treatment; all animals studied had a minimum egg count of at least 500 eggs per gram of feces (EPG). Post-mortem analyses were conducted on day 14. The highest levels of resistance to ivermectin were found for Haemonchus placei, Cooperia punctata and Oesophagostomum radiatum; all populations of H. placei were resistant to the 630µg/kg dose, and 67% were resistant to 700µg/kg; 86% of C. punctata were resistant to the 630µg/kg dose, and 33% were resistant to 700µg/kg. A combined analysis revealed that 57% of O. radiatum were resistant to the lower dose of ivermectin. H. placei, C. punctata and O. radiatum, in order, were the nematode populations with the highest indices of resistance, whereas Trichostrongylus axei was the most susceptible to 630 and 700µg/kg dosages of ivermectin. The results of helminthic resistance to ivermectin for different populations of H. placei and C. punctata described in the present study support previous literature data, in which a small decrease in the average parasitic burden of C. punctata and a consequent increase of H. placei were observed in cattle from the Southeast, South and Center-West regions of Brazil.


Subject(s)
Antiparasitic Agents/pharmacology , Cattle Diseases/parasitology , Ivermectin/pharmacology , Strongylida Infections/parasitology , Strongylida/drug effects , Animals , Brazil , Cattle , Cattle Diseases/drug therapy , Drug Resistance , Feces/parasitology , Male , Parasite Egg Count/veterinary , Strongylida/isolation & purification , Strongylida Infections/drug therapy , Treatment Outcome
5.
Vet Parasitol ; 189(2-4): 387-9, 2012 Oct 26.
Article in English | MEDLINE | ID: mdl-22612908

ABSTRACT

Anthelmintic resistance has emerged globally as a problem amongst nematode of livestock and has been particularly well documented in equine and small ruminants. There are no studies regarding the efficacy of anthelmintics against the hematophagous nematodes in ostriches, Libyostrongylus dentatus; and just a few on L. douglassii. Here the efficacy of albendazole, ivermectin and moxidectin were evaluated against these two species in an ostrich farm in Minas Gerais state, Brazil. The feces were collected on the day of treatment and after 13 days of an oral dose of albendazole (6 mg/kg), or an injected dose (0.2mg/kg) of ivermectin or moxidectin. The fecal egg count reduction test and coprocultures were performed to determine possible resistance against the drugs used. An efficacy of 60% was found for ivermectin, while albendazole and moxidectin were 100% effective. Both worm species appeared to have reduced sensitivity to ivermectin.


Subject(s)
Albendazole/pharmacology , Drug Resistance , Ivermectin/pharmacology , Macrolides/pharmacology , Strongylida/drug effects , Struthioniformes , Animals , Anthelmintics/pharmacology , Bird Diseases/drug therapy , Bird Diseases/parasitology , Strongylida Infections/drug therapy , Strongylida Infections/parasitology , Strongylida Infections/veterinary
6.
J Helminthol ; 85(2): 164-70, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20682085

ABSTRACT

Protease production from Duddingtonia flagrans (isolate AC001) was optimized and the larvicidal activity of the enzymatic extract was evaluated on infective horse cyathostomin larvae (L3). Duddingtonia flagrans was grown in liquid medium with eight different variables: glucose, casein, bibasic potassium phosphate (K2HPO4), magnesium sulphate (MgSO4), zinc sulphate (ZnSO4), ferrous sulphate (FeSO4), copper sulphate (CuSO4) and temperature. The Plackett-Burman analysis showed a significant influence of MgSO4, CuSO4 and casein (P < 0.05) on protease production by D. flagrans in liquid medium. Central composite design indicated that the highest proteolytic activity was 39.56 U/ml as a function of the concentrations of casein (18.409 g/l), MgSO4 (0.10 g/l) and CuSO4 (0.50 mg/l). A significant difference (P < 0.01) was found for the larval number between the treated and control groups at the end of the experiment. A reduction of 95.46% in the number of free-living larvae was found in the treated group compared with the control. The results of this study suggest that protease production by D. flagrans (AC001) in liquid medium was optimized by MgSO4, CuSO4 and casein, showing that the optimized enzymatic extract exerted larvicidal activity on cyathostomins and therefore may contribute to large-scale industrial production.


Subject(s)
Anthelmintics/metabolism , Anthelmintics/pharmacology , Duddingtonia/enzymology , Peptide Hydrolases/metabolism , Peptide Hydrolases/pharmacology , Strongylida/drug effects , Animals , Anthelmintics/isolation & purification , Culture Media/chemistry , Duddingtonia/growth & development , Horses , Larva/drug effects , Peptide Hydrolases/isolation & purification , Proteolysis , Survival Analysis
7.
Exp Parasitol ; 106(3-4): 150-7, 2004.
Article in English | MEDLINE | ID: mdl-15172222

ABSTRACT

The relationship between the pharmacokinetic behaviour and the anthelmintic efficacy of albendazole (ABZ) against benzimidazole (BZD)-resistant nematodes was studied in sheep. A micronized ABZ suspension was orally administered at two different dose levels to sheep naturally infected with BZD-resistant gastrointestinal (GI) nematodes. The experimental animals were allocated into the following groups (n = 8): (a) untreated control; (b) orally treated with ABZ at 3.8 mg/kg b.w.; and (c) orally treated with ABZ at 7.5 mg/kg b.w. Plasma samples were obtained serially over 72 h post-treatment from both treated groups and analysed by HPLC to measure the concentrations of ABZ and its sulphoxide (ABZSO) and sulphone (ABZSO(2)) metabolites. Faecal egg counts were performed prior to treatment and at the necropsy day. All experimental animals were sacrificed 10 days after treatment to perform GI worm counts. While ABZ parent drug was not recovered in the bloodstream, ABZSO and ABZSO(2) were the molecules found in plasma. ABZSO was the metabolite measured at the highest concentrations in the bloodstream for up to 36 (treatment at 3.8 mg/kg) or 60 h (treatment at 7.5 mg/kg) post-administration. There was a proportional relationship between the administered ABZ dose and the measured plasma concentrations of both ABZ metabolites. Over a 100% increment on the plasma AUC values for the anthelmintically active ABZSO metabolite was observed at the 7.5 mg/kg compared to the 3.8 mg/kg treatment. The low efficacy patterns (< 24%) observed against the GI nematodes investigated indicate a high level of resistance to ABZ given at 3.8 mg/kg an efficacious therapeutic dose rate recommended in some countries. However, the higher and prolonged plasma drug concentration measured after the 7.5 mg/kg treatment resulted in an improved efficacy pattern (estimated by both faecal egg and adult worm counts) against most of the GI nematodes studied compared to that obtained at the lower dose rate. A direct relationship between drug pharmacokinetic behaviour and anthelmintic efficacy against BZD-resistant nematodes in sheep was shown in the current work, although individual variation precluded the observation of statistically significant differences in worm counts.


Subject(s)
Albendazole/therapeutic use , Anthelmintics/therapeutic use , Intestinal Diseases, Parasitic/veterinary , Nematode Infections/veterinary , Sheep Diseases/drug therapy , Administration, Oral , Albendazole/pharmacokinetics , Albendazole/pharmacology , Animals , Anthelmintics/pharmacokinetics , Anthelmintics/pharmacology , Area Under Curve , Benzimidazoles/pharmacology , Chromatography, High Pressure Liquid/veterinary , Dose-Response Relationship, Drug , Drug Resistance , Feces/parasitology , Intestinal Diseases, Parasitic/drug therapy , Intestinal Diseases, Parasitic/metabolism , Nematode Infections/drug therapy , Nematode Infections/metabolism , Parasite Egg Count/veterinary , Random Allocation , Sheep , Sheep Diseases/metabolism , Sheep Diseases/parasitology , Strongylida/drug effects , Strongylida/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL